Compare ASMB & FTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | FTK |
|---|---|---|
| Founded | 2005 | 1985 |
| Country | United States | United States |
| Employees | N/A | 142 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 553.6M | 587.3M |
| IPO Year | 2010 | N/A |
| Metric | ASMB | FTK |
|---|---|---|
| Price | $30.81 | $19.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $43.40 | $20.00 |
| AVG Volume (30 Days) | 150.8K | ★ 331.9K |
| Earning Date | 11-10-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 242.12 |
| EPS | N/A | ★ 0.93 |
| Revenue | $37,191,000.00 | ★ $220,501,000.00 |
| Revenue This Year | $33.33 | $20.33 |
| Revenue Next Year | N/A | $12.59 |
| P/E Ratio | ★ N/A | $21.04 |
| Revenue Growth | ★ 31.30 | 23.56 |
| 52 Week Low | $7.75 | $6.05 |
| 52 Week High | $39.71 | $20.09 |
| Indicator | ASMB | FTK |
|---|---|---|
| Relative Strength Index (RSI) | 39.55 | 68.71 |
| Support Level | $31.73 | $16.94 |
| Resistance Level | $34.69 | $20.09 |
| Average True Range (ATR) | 2.07 | 0.95 |
| MACD | -0.36 | 0.21 |
| Stochastic Oscillator | 2.50 | 86.02 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.